Industries > Pharma > The Next Generation Sequencing Market Forecast 2017-2027

The Next Generation Sequencing Market Forecast 2017-2027

Revenue Prospects by Application (Drug Discovery, Genetic Screening, Diagnostics, Personalized Medicine, Agriculture and Animal Research, Infectious Diseases, Others) Technology (Whole-Genome Sequencing, Targeted Re-Sequencing, Exome Sequencing, RNA Seq, Chip Seq, De Novo Sequencing, Methyl Seq), Products, End User (Healthcare Institution, Academics, Biotechnology, Pharmaceutical) and Geography

PUBLISHED: 16 October 2017
PAGES: 248
PRODUCT CODE: PHA0247

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE

Next Generation Sequencing – our new study reveals trends, R&D progress, and predicted revenues
Where is the Next Generation Sequencing market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead
Our 248-page report provides 192 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Next Generation Sequencing market. See how to exploit the opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are 4 segmentations of the Next Generation Sequencing market, with forecasts for 7 Applications, 8 Technologies, 3 Product Types and 5 End Users, each forecasted at a global and regional level.

Global Next Generation Sequencing Market by Application
• Drug Discovery
• Genetic Screening
• Diagnostics
• Personalized Medicine
• Agriculture and Animal Research
• Infectious Diseases
• Others

Global Next Generation Sequencing Market by Technology
• Whole-Genome Sewuencing
• Targeted Re-Sequencing
• Exome Sequencing
• RNA Seq
• Chip Seq
• De Novo Sequencing
• Methyl Seq
• Others

Global Next Generation Sequencing Market by Product
• Instruments
• Reagents & Consumables
• Services

Global Next Generation Sequencing Market by End User
• Hospital & Healthcare Institution
• Academics
• Biotechnology
• Pharmaceutical
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 7 regional and 17 leading national markets:
• North America:
• US
• Canada

• Latin America:
• Brazil
• Mexico
• Rest of Latin America

• Western Europe:
• Germany
• The UK
• Italy
• France
• Spain
• Nordic
• Benelux
• Rest of Western Europe

The Next Generation Sequencing Market Forecast 2017-2027

• Eastern Europe:
• Russia
• Poland
• Rest of Eastern Europe

• Asia-Pacific:
• Japan
• China
• India
• Australia & New Zealand
• ASEAN
• Rest of Asia-Pacific

• MEA:
• GCC Countries
• South Africa
• Northern Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Next Generation Sequencing market, with a focus on this segment of these companies’ operations.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, Russia, Germany and China in particular, will continue to achieve high revenue growth to 2027.

Leading companies and the potential for market growth
Overall world revenue for Next Generation Sequencing will surpass $5.6bn in 2017, our work calculates. We predict strong revenue growth through to 2027.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Next Generation Sequencing Market report helps you
In summary, our 248-page report provides you with the following knowledge:
• Revenue forecasts to 2027 for 3 segmentations of the Next Generation Sequencing market, with forecasts for 7 Applications, 8 Technologies, 3 Products and 5 End Users Marine Derived Drug Types, 3 Sources and 5 Applications, each forecasted at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2027 for 6 regional and 21 key national markets – See forecasts for the Next Generation Sequencing market in North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, the UK, Italy, France, Nordic Countries, Benelux, China, India, Japan, Australia & New Zealand, ASEAN countries, GCC Countries, South Africa and Northern Africa.
• Stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market – including company profiles for 10 of the major companies involved in the Next Generation Sequencing market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain’s study is for everybody needing commercial analyses for the Next Generation Sequencing market and leading companies. You will find data, trends and predictions.

Get our report today The Next Generation Sequencing Market Forecast 2017-2027: Revenue Prospects by Application (Drug Discovery, Genetic Screening, Diagnostics, Personalized Medicine, Agriculture And Animal Research, Infectious Diseases, Others) Technology (Whole-Genome Sequencing, Targeted Re-Sequencing, Exome Sequencing, RNA Seq, Chip Seq, De Novo Sequencing, Methyl Seq, Others), Products (Instruments, Reagents & Consumables, Services), End User (Hospital & Healthcare Institution, Academics, Biotechnology, Pharmaceutical, Others) and Geography.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for The Next Generation Sequencing Market Forecast 2017-2027


Download sample pages

Complete the form below to download your free sample pages for The Next Generation Sequencing Market Forecast 2017-2027


Latest Pharma news

“The colon targeting drug delivery market will grow with exponential growth of 14% over the forecast period from 2020-2030”, says Visiongain

The colon targeting drug delivery market has been used various polymers including biodegradable polymers, guar gum, pectin, chondroitin sulfate, dextran, chitosan, cyclodextrin, inulin, amylose, locust bean gum, and others

23 September 2019

READ

“Global Diagnostic Imaging market set to grow to $32bn by 2024” says Visiongain report

Diagnostic imaging technology such as MRI and CT scans has become more precise and accessible, due to which radiology has increasingly become a key foundation of modern medicine.

20 September 2019

READ

“Oncology remains the largest disease area in the pharmaceutical business. The oncology market is dominated by big pharma companies and high price labels” says Visiongain report

Although price is still the most important competitive advantage for a biosimilar company, current discount rates are not enough to automatically convince the key stakeholders of a biosimilar’s value.

10 September 2019

READ

“Anti-Infective Agents market set to grow to $141bn by 2024” says new Visiongain report

The global anti-infective agents market is one that is driven by innovation. This is vital for maintaining the rich pipeline of anti-infective agents seen in the market today.

09 September 2019

READ

Categories

Category